Evidence map›Paper›PMID 42075832›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Development of a Luciferase-Based In Vitro Assay to Evaluate the Efficacy of Anti-Cryptosporidial Drugs Against

Rie Kubota, Coh-Ichi Nihei, Yoshifumi Nishikawa

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rie KubotaNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro 080-8555, Japan.ORCID 0009-0000-4330-263X
Coh-Ichi NiheiInstitute of Microbial Chemistry (BIKAKEN), 3-14-23 Kamiosaki, Tokyo 141-0021, Japan.
Yoshifumi NishikawaNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro 080-8555, Japan.ORCID 0000-0001-5005-6377

Funding

AKIYAMA LIFE SCIENCE FOUNDATION NAJapan Society for the Promotion of Science 25K18786Northern Advancement Center for Science & Technology T1-30Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development (AMED) 23fk0108682s0501
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-Cryptosporidium drugCryptosporidium parvumkijimicinluciferase-based assay

Identifiers

PMID42075832
PMCPMC13118926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.